Product image of Memantina Grindeks (Memantine Hydrochloride) supplied by GNH India

Memantina Grindeks

Active Ingredient:
Memantine Hydrochloride
Origin:
EU

Memantina Grindeks (Memantine Hydrochloride)

Memantine, the active ingredient in Memantina Grindeks, is a NMDA receptor antagonist presented as a tablet for oral use. It is indicated for the treatment of Alzheimer’s disease in adults.

GNH India supplies Memantina Grindeks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Grindeks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Memantina Grindeks is a NMDA receptor antagonist used in the management of Alzheimer’s disease.

  • Alzheimer’s disease (moderate to severe): improves cognition and daily functioning.
  • Alzheimer’s disease (behavioral symptoms): may reduce agitation and aggression.
  • Alzheimer’s disease (overall disease progression): helps slow functional decline.

How It Works

  • Memantine acts as a non‑competitive antagonist at the N‑methyl‑D‑aspartate (NMDA) receptor, binding within the ion channel and reducing excessive calcium influx. By moderating glutamate‑mediated excitotoxicity, it helps protect neurons from damage associated with over‑activation of NMDA receptors, which is implicated in Alzheimer’s disease pathology.

Side Effects

Memantina Grindeks may cause a range of adverse reactions.

Common Side Effects

  • Dizziness: transient sensation of light‑headedness.
  • Headache: mild to moderate intensity.
  • Constipation: reduced bowel movements.
  • Confusion: temporary mental clouding.
  • Fatigue: feeling unusually tired.
  • Nausea: mild stomach upset.

Serious or Rare Side Effects

  • Seizures: rare occurrence of convulsive episodes.
  • Allergic reactions: rash, itching, or swelling.
  • Stevens‑Johnson syndrome: severe skin reaction.
  • Hepatic dysfunction: abnormal liver enzymes.
  • Cardiac arrhythmias: irregular heart rhythm.
  • Psychosis: emergence of hallucinations or delusions.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Renal impairment: assess kidney function and adjust dose if needed.
  • Hepatic impairment: monitor liver enzymes regularly.
  • Cardiovascular disease: use with caution in patients with heart conditions.
  • Concomitant NMDA antagonists: avoid combined use to prevent additive toxicity.
  • Pregnancy and lactation: risk unknown; discuss with a healthcare professional.
  • Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Memantina Grindeks can interact with several medicines; monitoring is essential.

Major Interactions (Avoid)

  • Amantadine: combined NMDA antagonism may increase neurotoxicity.
  • Ketamine: additive CNS effects and heightened risk of seizures.
  • Dextromethorphan: may enhance neuropsychiatric adverse events.

Moderate Interactions (Monitor Closely)

  • Anticholinergic agents: may worsen cognitive side effects.
  • CNS depressants (e.g., benzodiazepines): increased sedation.
  • Diuretics: potential for electrolyte imbalance.
  • Antihypertensives: monitor blood pressure for additive hypotensive effect.
  • NSAIDs: watch for gastrointestinal irritation.

Frequently Asked Questions

Memantina Grindeks contains memantine hydrochloride and is prescribed to treat moderate to severe Alzheimer’s disease. It helps improve cognitive function and daily activities by reducing excitotoxic neuronal damage associated with the disease.

Memantine works as a non‑competitive antagonist of the NMDA receptor. By blocking excessive calcium entry through the receptor’s ion channel, it reduces glutamate‑induced excitotoxicity, thereby protecting neurons from damage that contributes to Alzheimer’s disease progression.

The specific dose and titration schedule for Memantina Grindeks are determined by the prescribing clinician based on the patient’s condition, renal function, and tolerability. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of memantine during pregnancy or lactation has not been fully established. Healthcare providers should weigh potential benefits against unknown risks and discuss alternative options with pregnant or nursing patients.

To request Memantina Grindeks, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Memantine belongs to the NMDA receptor antagonist class, differing from acetylcholinesterase inhibitors such as donepezil. While both classes aim to improve cognition, memantine targets glutamate‑mediated excitotoxicity, and is often used in moderate to severe stages, sometimes in combination with an acetylcholinesterase inhibitor for additive benefit.

Store Memantina Grindeks at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, heat and direct sunlight to maintain stability and potency throughout its shelf life.

Memantina Grindeks is taken orally, usually as a tablet, with or without food. The exact administration schedule, including dose titration, is set by the prescriber to match the patient’s therapeutic needs.

Serious adverse events, though rare, can include seizures, severe allergic reactions such as Stevens‑Johnson syndrome, hepatic dysfunction, cardiac arrhythmias, and psychotic symptoms. Patients should seek immediate medical attention if any of these occur.

Memantina Grindeks should be avoided in patients with known hypersensitivity to memantine or any excipients, and used with caution in those with severe renal or hepatic impairment, uncontrolled cardiovascular disease, or who are taking other NMDA antagonists.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Memantine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT